Number | 12 |
Male sex, N (%) | 8 (66 .7%) |
Age (years) | 44.5 (36.8-48.8) |
BMI | 27 (23.8-31) |
SAPS II | 36 (27.75-44.75) |
Patients with comorbidities, N (%) | 5 (41 .7%) |
Patients with proved coinfection, N (%) | 2 (16 .7%) |
Days from onset to ICU admission | 7 (6-8.25) |
§ PaO 2 (mmHg)/FiO 2 | 92 (53.5-119.5) |
§ PaCO 2 (mmHg) | 65 (39.9-83) |
§ pH | 7.37 (7.32-7.50) |
§ Respiratory rate (N/min) | 8.62 (6.87-11.3) |
§ White cells count (N*1000/ml) | 8.620 (6.870-11.300) |
§ Platelets count (N*1000/ml) | 158.5 (102-217.3) |
§ Lactate dehydrogenase (U/l) | 617 (391.2-919.8) |
§ Creatine kinase (U/l) | 611 (402.5-893.8) |
§ Aspartate aminotransferase (U/l) | 53.5 (39.8-121.3) |
§ Alanine aminotransferase (U/l) | 37.5 (27.3-43.5) |
§ C-reactive protein (mg/dl) | 80.5 (35.9-132.4) |
§ Serum creatinine (mg/dl) | 0.87 (0.69-1.26) |
§ Procalcitonin (ng/ml) | 3.2 (1.1-4.3) |
Chest radiographs (mean per patient) | 7.3 |
Chest CT-scan (mean per patient) | 1.25 |
Tracheostomy, N (%) | 5 (41 .7%) |
ECMO, N (%) | 7 (58 .3%) |
CVVH, N (%) | 2 (16 .7%) |
Duration of mechanical ventilation (days) | 13.5 (10.8-21.5) |
ICU lenght of stay (days) | 16.5 (10.5-25.5) |
Mortality, N (%) | 1 (8 .3%) |